The overexpression or induction of RECK may have therapeutic potential in hepatic fibrogenesis, inflammation, and damage linked to NAFLD/NASH as well as to hepatic I/R injury. Here, RECK is linked to metabolic dysfunction-associated steatotic liver disease.